HELX Among Health Care ETFs
End-of-day Nov 19, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −5.0% | −5.9% | −5.3% | +12.4% | +16.5% | +50.8% | −17.9% | — | +71.7% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$85 of every $1,000 in HELX is Guardant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GHGuardant Health | Healthcare | 8.50% | $849.98 | 19K | $2.8M |
| 2 | NTRANatera | Healthcare | 7.69% | $769.04 | 8,775 | $2.5M |
| 3 | KRYSKrystal Biotech | Healthcare | 5.19% | $518.84 | 5,435 | $1.7M |
| 4 | ADPTAdaptive Biotechnologies | Healthcare | 5.12% | $511.58 | 59K | $1.7M |
| 5 | LGNDLigand Pharmaceuticals | Healthcare | 4.60% | $459.82 | 5,085 | $1.5M |
| 6 | BBIOBridgebio Pharma | Healthcare | 3.54% | $354.31 | 15K | $1.2M |
| 7 | TWSTTwist Bioscience | Healthcare | 3.41% | $340.71 | 9,673 | $1.1M |
| 8 | MEDPMedpace | Healthcare | 2.96% | $295.50 | 1,509 | $976K |
| 9 | LLYELI Lilly | Healthcare | 2.87% | $286.74 | 685 | $947K |
| 10 | VRTXVertex Pharmaceuticals IN | Healthcare | 2.87% | $286.63 | 1,765 | $947K |
| 11 | UTHRUnited Therapeutics | Healthcare | 2.86% | $285.58 | 1,634 | $943K |
| 12 | REGNRegeneron Pharmaceuticals | Healthcare | 2.63% | $263.05 | 919 | $869K |
| 13 | TVTXTravere Therapeutics | Healthcare | 2.46% | $245.82 | 16K | $812K |
| 14 | VYLRVylor | Basic Materials | 2.21% | $220.94 | 10K | $730K |
| 15 | CDNACaredx | Healthcare | 2.06% | $206.02 | 9,142 | $681K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GH | Guardant Health | 8.50% |
| 2 | NTRA | Natera | 7.69% |
| 3 | KRYS | Krystal Biotech | 5.19% |
| 4 | ADPT | Adaptive Biotechnologies | 5.12% |
| 5 | LGND | Ligand Pharmaceuticals | 4.60% |
| 6 | BBIO | Bridgebio Pharma | 3.54% |
| 7 | TWST | Twist Bioscience | 3.41% |
| 8 | MEDP | Medpace | 2.96% |
| 9 | LLY | ELI Lilly & | 2.87% |
| 10 | VRTX | Vertex Pharmaceuticals IN | 2.87% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 8, 2026 | $0.14 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0039 |
| Dec 13, 2021 | Dec 21, 2021 | $0.11 |
| Dec 14, 2020 | Dec 23, 2020 | $0.0520 |